Transported Asset Protection Association EMEA ’s Post

👉 ABOUT US: "Laura Cunningham" Laura and her team are taking care of all Contract Logistics activities and that all products are stored safely in our warehouse. Find out more about Laura and her daily life as Manager Contract Logistics, through her video in the comments below. #aboutus #team #logistics #pharma 🔔 Follow us to learn more and activate the bell to ensure you don't miss our posts!

The strength of collaboration and partnership!

🌟 Delighted to have had the opportunity to participate in the 4th Middle East Risk and Compliance Conference, a leading platform for exploring the dynamic landscape of pharmaceutical compliance and risk. The conference offered valuable insights and an opportunity to learn from influential figures in pharmaceutical compliance. Looking forward to continued collaboration and growth as we navigate the exciting challenges ahead! #PharmaCompliance #RiskManagement

🏆 Did you know? Biocair and Aramex Ireland have been shortlisted for the Pharma Industry Awards Partnership Alliance of the Year. The partnership between Biocair and Aramex represents a significant advancement for life science companies in Ireland. By leveraging Aramex's extensive logistics capabilities and Biocair's specialized expertise, customers now have access to tailored end-to-end solutions that meet their unique needs. Highlighting the expansion of logistics solutions resulting from the partnership, Peter Canning says, “By combining Biocair's expertise with our own, we’re able to create tailored solutions for customers.” Darragh Scannell shared the success of the collaboration, citing positive customer feedback as evidence of its effectiveness. “From the moment we first engaged with Biocair and Aramex Ireland it was evident that they prioritise customer satisfaction. Their team of professionals demonstrated exceptional knowledge and expertise in handling the unique logistics challenges of the pharmaceutical industry. They understood the criticality of time-sensitive shipments and the importance of maintaining product integrity throughout the supply chain.” - Supply Chain Lead, Dublin Global CDMO Learn more about our recent updates in our monthly round up 👇 https://hubs.li/Q02RRy4Q0 #PharmaAwards #Ireland #PartnershipAlliance #Biocair #AramexIreland #Pharma #SupplyChain

Delivering innovation for the Pharma sector.

We are honored to welcome Rick Greville, Director, ABPI Wales Cymru & Distribution Supply Chain, The Association of the British Pharmaceutical Industry as a Panelist on a Panel Discussion titled 'The Global Threat of Trade in Falsified Medicines: A Danger to Health and Development' on the 23rd of April 2024, at the upcoming EMEA Security Conference & Exhibition | High Security Printing, Anti-Counterfeiting, & Brand Protection held at Copthorne Tara Hotel in London, United Kingdom. Rick is an ABPI Director with responsibility for Wales and the Distribution & Supply Chain. He was initially appointed to the post of Director of ABPI Cymru Wales in May 2003 after serving an apprenticeship of 15 years in a wide range of managerial and marketing roles within the pharmaceutical industry. Since April 2014 Richard has combined his continuing ABPI responsibility for Wales with that for the UK Distribution and Supply Chain, including homecare, the Falsified Medicines Directive and supply chain shortages. Over recent times he has developed ABPI policy in response to Brexit, Covid-19, and the Ukrainian war. He is a founding Director of SecurMed UK, the UK (NI) medicines verification organisation, a long-standing member of the National Homecare Medicines Committee and represents the industry on several Governmental Advisory Groups. Get in touch with ABPI Representatives & members at the EMEA Security Conference & Exhibition; An event that brings together an international audience of over 150 leading specialists discussing latest trends, developments, threats and solutions relating to illicit trade & counterfeiting across industries. We look forward to you joining the discussion, sharing your knowledge, and networking with industry experts, colleagues and friends from around the globe. Secure your spot, Register now at https://lnkd.in/gGrckupx #EMEASec2024 #brandprotection #counterfeiting #illicittrade #authentication #brands #consumersafety #piracy #security #innovation #traceability #supplychain #intellectualproperty #intellectualpropertyrights #ipr #sustainable #collaboration #publicprivatepartnerships #health #development #pharmaceutical #healthandsafety #intelligence #lawenforcement #healthcare #medicine #medicaldevices #supplychain #litigation #networking #business #event #technology #opportunities #leaders #partnerships 

CAPDM was among the invitees to the GIRP - European Healthcare Distribution Association 65th Annual Meeting and Conference, represented by Nancy Beshay. Attended by dozens of healthcare distribution associations in Europe and around the world, this global network explores information and shares best practices on drug shortages, regulations, supply chain security, and more.    #Pharmacy #SupplyChain #GIRPAMC2024

TAPA EMEA's President & CEO, Thorsten Neumann will be one of the speakers participating in the ‘Pharmaceutical Distribution’ conference in Cologne on 9-10 September to raise more awareness of #security #risks in the #supplychain for #pharma manufacturers, distributors, and #logistics providers. TAPA EMEA’s membership already includes a high number of the world’s leading #pharmaceutical organisations but we believe many more businesses in this sector can benefit from the industry standards, intelligence, training, and networking connections our Association can provide. The potential risk to public health means #cargo #thefts targeting pharma products can have extremely costly and far-reaching impacts. Pharma supply chains are generally extremely resilient because of these risks – but the level of threats from #organisedcrime and others means maintaining the highest levels of risk #intelligence is a vital component to protect the security of #supplychains. On 10 September, Thorsten will be presenting an overview of these risks, looking at current #trends, and discussing how TAPA EMEA can help pharma companies and their supply chain partners maintain #supplychainresilience.         Fine out more about ‘Pharmaceutical Distribution’ here: https://lnkd.in/e-4Mk3Nd #tapaemea #tapa #pharmalogistics

Our panellist at our #Pharma #AntiCounterfeiting, #Serialisation & #SupplyChain Security 2024 will be Steven Ustel, Jyrki Syvaeri, Jonathan Buisson, Vineet Khanna, Cameron McKinnell, Demet Tazegul https://lnkd.in/gjprg46v For our upcoming conferences visit : https://lnkd.in/gjQY86dn Fen Castro Piyush Patel #VIpsscs #VIpasscs #trackandtrace #traceability #supplychainsecurity #brandprotection #anticounterfeit #vipacs #Counterfeit #manufacturing #logistics #OperationAncord #lascarancord #ancord #packaging #smartpackaging #packaginginnovation #pharmalabelling #artwork #pharmalabels #scm #Healthcare #TrackTrace #drugs #medicines #Anticounterfeiting #Drugregulatory #Pharmaceuticals #clinicaltrials #clinicalresearch #Qualitycontrol #RegulatoryAffairs #pharmanews #regulatory #pharmaceuticalindustry #biotech 

Partnership for DSCSA Governance (PDG)/FDA Joint Public Meeting: DSCSA Stabilization Period Midway Checkpoint JUNE 17 - 18, 2024 About: The Partnership for DSCSA Governance (PDG) and FDA are hosting a joint public meeting on the Drug Supply Chain Security Act (DSCSA) implementation and stabilization efforts. This free meeting serves as a checkpoint midway in the stabilization period, affording industry, FDA and others an opportunity to share stabilization progress that has been made, stabilization activity that remains and areas of remaining concern. The meeting provides representative stakeholder groups an opportunity to share information that supports all stakeholders in efficiently executing the remaining steps needed to achieve enhanced product tracing together. This includes: 1.Expanding on the insights shared through FDA’s request for information, “Implementing Interoperable Systems and Processes for Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act”industry progress captured by PDG